Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) rallied 2.55% to $615.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.25% to 4,001.05 and the Dow Jones Industrial Average falling 0.26% to 32,160.74. The stock's rise snapped a three-day losing streak. Regeneron Pharmaceuticals Inc. closed $132.33 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.14% to $177.09, Novartis AG ADR (NOVN.EB) rose 1.09% to $84.39, and Amgen Inc. (AMGN) rose 0.61% to $240.71. Trading volume (769,478) eclipsed its 50-day average volume of 655,931.
Data source: Dow Jones Market Data, FactSet. Data compiled May 10, 2022.
(END) Dow Jones Newswires
May 10, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.